Enter assignee name

EPO Patents = 1

Forward Citations = 14

Loading Chart...

8 inventors (with patents filed for the assignee):

Binh Vu (9 out of 24 patents)

Hongju Li (8 out of 15 patents)

Romyr Dominique (8 out of 21 patents)

4. Bruce Fahr (5 out of 5 patents)

5. Andrew Charles Good (3 out of 58 patents)

6. Yi Heng Chen (2 out of 77 patents)

7. Melissa Dumble (2 out of 2 patents)

8. Arnold Levine (1 out of 3 patents)

11 patents: Sort by Forward Citations

1. 12428406 - Methods and compounds for restoring mutant p53 function (2025-09-30),

2. 12419880 - Companion diagnostic tool for mutant p53 reactivating compounds (2025-09-23),

3. 11963953 - Deuterated compounds for restoring mutant p53 function (2024-04-23),

4. 11938124 - Combination therapy for treatment of cancer (2024-03-26),

5. 11926632 - Methods and compounds for restoring mutant p53 function (2024-03-12),

6. 11814373 - Methods and compounds for restoring mutant p53 function (2023-11-14),

7. 11807644 - Methods and compounds for restoring mutant p53 function (2023-11-07),

8. 11731953 - Methods and compounds for restoring mutant p53 function (2023-08-22),

9. 11339141 - Methods and compounds for restoring mutant p53 function (2022-05-24),

10. 10640485 - Methods and compounds for restoring mutant p53 function (2020-05-05),

11. 10138219 - Methods and compounds for restoring mutant p53 function (2018-11-27),

Pmv Pharmaceuticals, Inc. is a clinical stage precision oncology company focused on developing targeted therapies for patients with cancer. The company's lead product candidate, PMV-01, is a potent and selective inhibitor of a genetic driver of cancer. Pmv Pharma's innovative approach aims to transform the treatment of cancer by targeting specific genetic mutations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#10 in Cranbury, NJ

#1,024 in New Jersey

#26,743 in US

#50,237 in the World

Cranbury, NJ, United States of America

Pmv Pharmaceuticals, Inc.